Clive Bertram is the Chief Business Officer at Deep Genomics. He comes with over 30 years of experience in commercialization, strategic, corporate and business development in the pharmaceutical industry. Most recently, he served as CCO at ObsEva, Petra Pharma and Sangart. Prior to his CCO roles, Clive held multiple senior management positions at Pharmion Limited, Chiron Biopharmaceuticals, Celltech and Eli Lilly. Clive has also served as an independent consultant leading client thinking for strategic and marketing planning and business development.

He holds a BSc (Hons.) in Pharmacology and Chemistry from the University of Sheffield

• 

  Chief Business Officer in Deep Genomics

  Biotechnology Research